CoChat

Antioxidants halt axonal degeneration in a mouse model of X‐adrenoleukodystrophy

Open access
López‐Erauskin, Jone, Fourcade, Stéphane, Galino, Jorge, Ruiz, Montserrat, Schlüter, Agatha, Naudi, Alba, Jove, Mariona, Portero‐Otin, Manuel, Pamplona, Reinald, Ferrer, Isidre, Pujol, Aurora · 2011 · Annals of Neurology
Cited by 135

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Abstract

Objective: Axonal degeneration is a main contributor to disability in progressive neurodegenerative diseases in which oxidative stress is often identified as a pathogenic factor. We aim to demonstrate that antioxidants are able to improve axonal degeneration and locomotor deficits in a mouse model of X‐adrenoleukodystrophy (X‐ALD). Methods: X‐ALD is a lethal disease caused by loss of function of the ABCD1 peroxisomal transporter of very long chain fatty acids (VLCFA). The mouse model for X‐ALD exhibits a late onset neurological phenotype with locomotor disability and axonal degeneration in spinal cord resembling the most common phenotype of the disease, adrenomyeloneuropathy (X‐AMN). Recently, we identified oxidative damage as an early event in life, and the excess of VLCFA as a generator of radical oxygen species (ROS) and oxidative damage to proteins in X‐ALD. Results: Here, we prove the capability of the antioxidants N‐acetyl‐cysteine, α‐lipoic acid, and α‐tocopherol to scavenge VLCFA‐dependent ROS generation in vitro. Furthermore, in a preclinical setting, the cocktail of the 3 compounds reversed: (1) oxidative stress and lesions to proteins, (2) immunohistological signs of axonal degeneration, and (3) locomotor impairment in bar cross and treadmill tests. Interpretation: We have established a direct link between oxidative stress and axonal damage in a mouse model of neurodegenerative disease. This conceptual proof of oxidative stress as a major disease‐driving factor in X‐AMN warrants translation into clinical trials for X‐AMN, and invites assessment of antioxidant strategies in axonopathies in which oxidative damage might be a contributing factor. Ann Neurol 2011;

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ana.22363

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 18 references

Cited by

See all 135

Metadata

Authors
López‐Erauskin, J., Fourcade, S., Galino, J., Ruiz, M., Schlüter, A., Naudi, A., Jove, M., Portero‐Otin, M., Pamplona, R., Ferrer, I., & Pujol, A.
Venue
Annals of Neurology
Publisher
Wiley
Published
2011-07
Volume
70
Issue
1
Pages
84-92
ISSN
  • 0364-5134 (ISSN-L)
  • 1531-8249
OpenAlex
W2039294355
Cited by
135
References
18
FWCI
8.17
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Antioxidants halt axonal degeneration in a mouse model of X‐adrenoleukodystrophy. https://app.cochat.ai/papers/10.1002/ana.22363
The paper
López‐Erauskin, J., Fourcade, S., Galino, J., Ruiz, M., Schlüter, A., Naudi, A., Jove, M., Portero‐Otin, M., Pamplona, R., Ferrer, I., & Pujol, A. (2011). Antioxidants halt axonal degeneration in a mouse model of X‐adrenoleukodystrophy. Annals of Neurology. https://doi.org/10.1002/ana.22363

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.